FI103972B1 - A process for the preparation of purine nucleoside phosphorylase inhibitors - Google Patents

A process for the preparation of purine nucleoside phosphorylase inhibitors

Info

Publication number
FI103972B1
FI103972B1 FI921900A FI921900A FI103972B1 FI 103972 B1 FI103972 B1 FI 103972B1 FI 921900 A FI921900 A FI 921900A FI 921900 A FI921900 A FI 921900A FI 103972 B1 FI103972 B1 FI 103972B1
Authority
FI
Finland
Prior art keywords
preparation
purine nucleoside
nucleoside phosphorylase
phosphorylase inhibitors
inhibitors
Prior art date
Application number
FI921900A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI921900A (en
FI921900A0 (en
FI103972B (en
Inventor
John A Secrist Iii
Mark David Erion
John A Montgomery
Steven E Ealick
Wayne C Guida
Shri Niwas
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/429,098 external-priority patent/US4985434A/en
Priority claimed from US07/429,097 external-priority patent/US5008270A/en
Priority claimed from US07/429,099 external-priority patent/US5008265A/en
Priority claimed from US07/429,100 external-priority patent/US4985433A/en
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of FI921900A publication Critical patent/FI921900A/en
Publication of FI921900A0 publication Critical patent/FI921900A0/en
Application granted granted Critical
Publication of FI103972B publication Critical patent/FI103972B/en
Publication of FI103972B1 publication Critical patent/FI103972B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/35—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI921900A 1989-10-31 1992-04-28 A process for the preparation of purine nucleoside phosphorylase inhibitors FI103972B1 (en)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US42909889 1989-10-31
US07/429,098 US4985434A (en) 1989-10-31 1989-10-31 7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
US07/429,097 US5008270A (en) 1989-10-31 1989-10-31 2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US07/429,099 US5008265A (en) 1989-10-31 1989-10-31 2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US07/429,100 US4985433A (en) 1989-10-31 1989-10-31 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US42909989 1989-10-31
US42910089 1989-10-31
US42909789 1989-10-31
US44279889A 1989-11-29 1989-11-29
US44279889 1989-11-29
US9005756 1990-10-12
PCT/US1990/005756 WO1991006548A1 (en) 1989-10-31 1990-10-12 Inhibitors of purine nucleoside phosphorylase

Publications (4)

Publication Number Publication Date
FI921900A FI921900A (en) 1992-04-28
FI921900A0 FI921900A0 (en) 1992-04-28
FI103972B FI103972B (en) 1999-10-29
FI103972B1 true FI103972B1 (en) 1999-10-29

Family

ID=27541578

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921900A FI103972B1 (en) 1989-10-31 1992-04-28 A process for the preparation of purine nucleoside phosphorylase inhibitors

Country Status (9)

Country Link
EP (1) EP0500653A4 (en)
JP (1) JP2866478B2 (en)
AU (1) AU654264B2 (en)
CA (1) CA2072123C (en)
FI (1) FI103972B1 (en)
HU (1) HUT61765A (en)
LV (1) LV10100B (en)
NO (1) NO301423B1 (en)
WO (1) WO1991006548A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726311A (en) * 1989-11-29 1998-03-10 Biocryst Pharmaceuticals, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo 3,2-d!pyrimidine and pharmaceutical uses and compositions containing the same
US5236926A (en) * 1992-02-03 1993-08-17 Warner-Lambert Company 9-substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors or PNP for pharmaceutical compositions
CA2133346A1 (en) * 1992-04-21 1993-10-28 Shri Niwas 7-disubstituted-methyl-4-oxo-3h,5h-pyrrolo[3,2-d]pyrimidine and pharmaceutical uses and compositions containing the same
PL319485A1 (en) * 1994-10-05 1997-08-04 Chiroscience Ltd Purinic and guanic compounds as pnp inhibitors
GB9520364D0 (en) * 1995-10-05 1995-12-06 Chiroscience Ltd Compouundds
GB9520363D0 (en) * 1995-10-05 1995-12-06 Chiroscience Ltd Compounds
CN1107068C (en) * 1997-05-29 2003-04-30 诺瓦提斯公司 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo (3,2-D] pyrimidine-4-ones
US6174888B1 (en) 1998-05-28 2001-01-16 Novartis Ag 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones
JP4496586B2 (en) * 2000-01-24 2010-07-07 日産化学工業株式会社 Process for producing quinolylacrylonitrile and its intermediate
RU2330042C2 (en) * 2002-08-21 2008-07-27 Альберт Эйнштейн Колледж Оф Медсин Оф Йешива Юниверсити Nucleoside phosphorylases and nucleosidases inhibitors
NZ523970A (en) * 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
WO2009079797A1 (en) 2007-12-26 2009-07-02 Critical Outcome Technologies, Inc. Compounds and method for treatment of cancer
CA2999321A1 (en) 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
US8987272B2 (en) 2010-04-01 2015-03-24 Critical Outcome Technologies Inc. Compounds and method for treatment of HIV

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5988484A (en) * 1982-11-09 1984-05-22 Takeda Chem Ind Ltd Novel 7-deazapurine derivative
IE60433B1 (en) * 1986-08-26 1994-07-13 Warner Lambert Co Novel 9-deazaguanines
US4921858A (en) * 1986-10-24 1990-05-01 Warner-Lambert Company 7-deazaguanines as immunomodulators
CA1294960C (en) * 1986-10-24 1992-01-28 Thomas C. Malone 7-deazaguanines as immunomodulators
DE3726044A1 (en) * 1987-02-11 1988-08-25 Bayer Ag ACARICIDES ON THE BASIS OF AZOMETHINE DERIVATIVES AND AZOMETHINE OF 2,3-DIAMINOMALEAINSAURENITRILE
US4927830A (en) * 1988-04-08 1990-05-22 The Regents Of The University Of Michigan Acyclic pyrrolo[2,3-D]pyrimidine analogs as antiviral agents
JP2760364B2 (en) * 1989-02-27 1998-05-28 バイオクライシス・ファーマシューティカルズ、インコーポレイテッド 9-substituted-8-unsubstituted-9-deazaguanines
US4985434A (en) * 1989-10-31 1991-01-15 Biocryst, Inc. 7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
US4985433A (en) * 1989-10-31 1991-01-15 Biocryst, Inc. 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same

Also Published As

Publication number Publication date
FI921900A (en) 1992-04-28
HUT61765A (en) 1993-03-01
LV10100A (en) 1994-05-10
EP0500653A4 (en) 1995-08-23
FI921900A0 (en) 1992-04-28
NO921679D0 (en) 1992-04-29
HU9201450D0 (en) 1992-09-28
FI103972B (en) 1999-10-29
NO301423B1 (en) 1997-10-27
AU6712590A (en) 1991-05-31
WO1991006548A1 (en) 1991-05-16
AU654264B2 (en) 1994-11-03
JP2866478B2 (en) 1999-03-08
LV10100B (en) 1995-08-20
CA2072123A1 (en) 1991-05-01
CA2072123C (en) 2001-06-12
EP0500653A1 (en) 1992-09-02
JPH05504551A (en) 1993-07-15
NO921679L (en) 1992-06-17

Similar Documents

Publication Publication Date Title
EP0409595A3 (en) Process for the preparation of a carbocyclic nucleoside analogue
PT96321A (en) PROCESS FOR THE PREPARATION OF PURINE NUCLEOSIDES
FI102680B1 (en) Process for preparing novel therapeutically useful purine nucleosides
PT89482A (en) PROCESS FOR THE PREPARATION OF DISESOXYDESIDRO-CARBOXYLIC NUCLEOSIDE DERIVATIVES
DE3856154D1 (en) Adenosine derivatives
PT87707A (en) PROCESS FOR THE PREPARATION OF 2-ANYLINO PYRIMIDINE DERIVATIVES
PT86660A (en) PROCESS FOR PREPARING ADENOSINE 5: -CARBOXAMIDE DERIVATIVES
PT91188A (en) PROCESS FOR THE PREPARATION OF FURANO DERIVATIVES
PT87191A (en) PROCESS FOR THE PREPARATION OF NUCLEOSIDES
DK375989A (en) purine derivatives
FI895417A0 (en) Process for the preparation of new therapeutically useful 2'-halomethylidene nucleosides
FI103972B1 (en) A process for the preparation of purine nucleoside phosphorylase inhibitors
FI890028A0 (en) Process for the preparation of 2-substituted adenosine derivatives
FI891339A0 (en) A process for the preparation of new therapeutically useful aristeromycin / adenosine derivatives
PT91749A (en) PROCESS FOR THE PREPARATION OF PURINE DERIVATIVES
FI883889A (en) A process for the preparation of new therapeutically useful aristeromycin / adenosine derivatives
LTIP539A (en) Inhibitors of purine nucleoside phosphorylase and process for preparing thereof
DK630589A (en) 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION
OA09697A (en) Nucleoside derivatives
YU199688A (en) Process for obtaining purine derivatives
PT88143A (en) PROCESS FOR THE PREPARATION OF PURINE DERIVATIVES
PT87705A (en) PROCESS FOR THE PREPARATION OF 6-DEOXY GUANINE DERIVATIVE
DK339189A (en) purine derivatives
AU628571B2 (en) Phosphonate derivatives of purine
PT87605A (en) PROCESS FOR THE PREPARATION OF THE (S) -ISOMER OF A PURINE DERIVATIVE